0 XP   0   0   0

Blueprint Medicines Corp
Buy or Sell?

I guess you are interested in Blueprint Medicines Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Blueprint Medicines Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Blueprint Medicines Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Blueprint Medicines Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Blueprint Medicines Corp. The closing price on 2022-09-23 was $65.57 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Blueprint Medicines Corp
Blueprint Medicines Corp Daily Candlestick Chart

1.1. Profitability of Blueprint Medicines Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Blueprint Medicines Corp:

  • The MRQ is -437.0%. The company is losing money. -2
  • The TTM is -347.1%. The company is losing money. -2
Trends
Current periodCompared to+/- 
MRQ-437.0%TTM-347.1%-89.9%
TTM-347.1%YOY-256.4%-90.7%
TTM-347.1%5Y-2,233.3%+1,886.2%
5Y-2,233.3%10Y-1,420.5%-812.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-437.0%-242.4%-194.6%
TTM-347.1%-275.9%-71.2%
YOY-256.4%-328.0%+71.6%
5Y-2,233.3%-464.6%-1,768.7%
10Y-1,420.5%-547.1%-873.4%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Blueprint Medicines Corp:

  • The MRQ is -13.4%. Very bad. -2
  • The TTM is -14.0%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-14.0%+0.6%
TTM-14.0%YOY5.7%-19.7%
TTM-14.0%5Y-8.3%-5.7%
5Y-8.3%10Y-26.2%+17.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.4%-9.8%-3.6%
TTM-14.0%-8.8%-5.2%
YOY5.7%-9.2%+14.9%
5Y-8.3%-11.6%+3.3%
10Y-26.2%-12.7%-13.5%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Blueprint Medicines Corp:

  • The MRQ is -21.4%. Very bad. -2
  • The TTM is -18.9%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-21.4%TTM-18.9%-2.5%
TTM-18.9%YOY6.7%-25.6%
TTM-18.9%5Y-11.4%-7.5%
5Y-11.4%10Y-10.7%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.4%-11.9%-9.5%
TTM-18.9%-11.2%-7.7%
YOY6.7%-10.6%+17.3%
5Y-11.4%-13.7%+2.3%
10Y-10.7%-14.5%+3.8%

1.2. Operating Efficiency of Blueprint Medicines Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Blueprint Medicines Corp:

  • The MRQ is -427.3%. Very bad. -2
  • The TTM is -343.6%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-427.3%TTM-343.6%-83.6%
TTM-343.6%YOY-257.2%-86.4%
TTM-343.6%5Y-2,303.5%+1,959.9%
5Y-2,303.5%10Y-1,459.4%-844.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-427.3%-232.1%-195.2%
TTM-343.6%-269.6%-74.0%
YOY-257.2%-306.8%+49.6%
5Y-2,303.5%-461.8%-1,841.7%
10Y-1,459.4%-546.8%-912.6%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 5.313. Good. +1
  • The TTM is 4.449. Very good. +2
Trends
Current periodCompared to+/- 
MRQ5.313TTM4.449+0.865
TTM4.449YOY3.573+0.876
TTM4.4495Y42.410-37.961
5Y42.41010Y27.643+14.767
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3133.321+1.992
TTM4.4493.662+0.787
YOY3.5733.692-0.119
5Y42.4105.743+36.667
10Y27.6436.919+20.724

1.3. Liquidity of Blueprint Medicines Corp.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 5.998. Very Good. +2
  • The TTM is 5.290. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ5.998TTM5.290+0.707
TTM5.290YOY7.173-1.883
TTM5.2905Y8.010-2.720
5Y8.01010Y7.261+0.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9985.318+0.680
TTM5.2906.219-0.929
YOY7.1736.366+0.807
5Y8.0106.760+1.250
10Y7.2616.520+0.741
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 9.840. Very good. +2
  • The TTM is 7.735. Very good. +2
Trends
Current periodCompared to+/- 
MRQ9.840TTM7.735+2.105
TTM7.735YOY8.220-0.485
TTM7.7355Y12.481-4.746
5Y12.48110Y10.430+2.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.8404.101+5.739
TTM7.7354.994+2.741
YOY8.2205.256+2.964
5Y12.4815.338+7.143
10Y10.4305.050+5.380

1.4. Solvency of Blueprint Medicines Corp.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 0.373. Very good. +2
  • The TTM is 0.246. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.373TTM0.246+0.127
TTM0.246YOY0.147+0.098
TTM0.2465Y0.222+0.024
5Y0.22210Y0.375-0.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3730.269+0.104
TTM0.2460.267-0.021
YOY0.1470.297-0.150
5Y0.2220.362-0.140
10Y0.3750.398-0.023
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 0.595. Very good. +2
  • The TTM is 0.342. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.595TTM0.342+0.253
TTM0.342YOY0.173+0.169
TTM0.3425Y0.299+0.043
5Y0.29910Y0.282+0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5950.305+0.290
TTM0.3420.303+0.039
YOY0.1730.309-0.136
5Y0.2990.382-0.083
10Y0.2820.436-0.154

2. Market Valuation of Blueprint Medicines Corp

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Blueprint Medicines Corp:

  • The EOD is -5.525. Company is losing money. -2
  • The MRQ is -4.256. Company is losing money. -2
  • The TTM is -8.568. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.525MRQ-4.256-1.269
MRQ-4.256TTM-8.568+4.312
TTM-8.568YOY17.542-26.110
TTM-8.5685Y-6.548-2.020
5Y-6.54810Y-6.298-0.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.525-2.088-3.437
MRQ-4.256-2.275-1.981
TTM-8.568-3.793-4.775
YOY17.542-4.994+22.536
5Y-6.548-3.642-2.906
10Y-6.298-3.303-2.995
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Blueprint Medicines Corp:

  • The MRQ is 0.014. Very good. +2
  • The TTM is 0.032. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.014TTM0.032-0.018
TTM0.032YOY-0.101+0.133
TTM0.0325Y-0.450+0.482
5Y-0.45010Y-0.388-0.062
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0140.005+0.009
TTM0.0320.020+0.012
YOY-0.1010.041-0.142
5Y-0.4500.021-0.471
10Y-0.3880.017-0.405

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Blueprint Medicines Corp:

  • The EOD is 5.228. Seems overpriced? -1
  • The MRQ is 4.027. Neutral. Compare to industry.
  • The TTM is 4.917. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD5.228MRQ4.027+1.201
MRQ4.027TTM4.917-0.890
TTM4.917YOY4.040+0.877
TTM4.9175Y5.932-1.015
5Y5.93210Y4.653+1.279
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.2281.808+3.420
MRQ4.0271.944+2.083
TTM4.9172.750+2.167
YOY4.0403.490+0.550
5Y5.9322.731+3.201
10Y4.6532.401+2.252

2.4. Latest News of Blueprint Medicines Corp

Does Blueprint Medicines Corp still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Blueprint Medicines Corp to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-08
17:30
Why Is Exelixis (EXEL) Down 8.8% Since Last Earnings Report?Read
2022-09-07
17:30
Reata Pharmaceuticals, Inc. (RETA) Up 4.7% Since Last Earnings Report: Can It Continue?Read
2022-09-07
00:59
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Blueprint Medicines Corporation Investors to Inquire About Class Action Investigation – BPMCRead
2022-09-01
17:31
Blueprint Medicines (BPMC) Up 22.7% Since Last Earnings Report: Can It Continue?Read

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Blueprint Medicines Corp.

3.1. Institutions holding Blueprint Medicines Corp

Institutions are holding 111.853% of the shares of Blueprint Medicines Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Vanguard Group Inc9.25170.00845525060-8711-0.1574
2022-03-31FMR Inc8.93070.027253333812984929127.102
2022-03-31T. Rowe Price Associates, Inc.8.26050.031849331253825868.4075
2022-03-31Wellington Management Company LLP6.54550.0428390894443161912.4124
2022-03-31State Street Corporation3.79590.0072226689453542430.9231
2022-03-31Cadian Capital Management LP3.21736.12819213471470690326.3435
2022-03-31JPMorgan Chase & Co2.8050.01291675124309631.8832
2022-03-31AllianceBernstein L.P.2.53010.03731510991102460.6827
2022-06-30Westfield Capital Management Company, LP2.31890.5507138481021138918.0148
2022-03-31Farallon Capital Management, L.L.C.2.27230.4605135698754524067.1687
2022-03-31Macquarie Group Ltd2.06450.05991232928-43834-3.4332
2022-06-30Casdin Capital, LLC1.92574.91131150000-400000-25.8065
2022-03-31Alkeon Capital Management, LLC1.91550.14641143899-128601-10.1062
2022-03-31William Blair Investment Management, LLC1.81770.20721085516-662205-37.8896
2022-03-31Geode Capital Management, LLC1.73580.0083103660866770.6483
2022-06-30Brown Advisory Holdings Inc1.60690.0784959644462425.0626
2022-03-31Rock Springs Capital Management LP1.58691.52399477158796010.2308
2022-03-31American Century Companies Inc1.26710.033756725-108056-12.4952
2022-06-30Aquilo Capital Management, LLC1.199812.3507716539-65000-8.3169
2022-03-31Eventide Asset Management, LLC0.99210.59359250019670049.6968
Total 66.039927.218939438737  

3.2. Funds holding Blueprint Medicines Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv2.98810.00751784505155020.8763
2022-06-30Fidelity® Select Biotechnology2.59751.6134155122059395862.0476
2022-07-31Vanguard Small Cap Index2.52290.0633150666837360.2486
2022-07-31SPDR® S&P Biotech ETF2.51411.01741501416-10504-0.6947
2022-06-30T. Rowe Price New Horizons2.32140.30391386315918037.0917
2022-06-30Vanguard Health Care Inv2.18730.1453130624800
2022-07-29iShares Russell 2000 ETF2.15570.1227128737211250.0875
2022-06-30Fidelity Advisor® Biotechnology I1.78023.3552106310023038327.6664
2022-06-30Strategic Advisers® Fidelity US TtlStk1.62560.077597079817098521.3781
2022-06-30Delaware Small Cap Core I1.53140.691391455500
2022-06-30Macquarie US Small Cap Core Equity1.53140.6921914555444025.1028
2022-07-31Vanguard Small Cap Growth Index Inv1.48960.1547889580-853-0.0958
2022-07-31Vanguard Extended Market Index Investor1.32140.046378913941970.5347
2022-06-30T. Rowe Price Health Sciences1.25090.2431747024-8989-1.189
2022-06-30Fidelity® Select Health Care1.17210.445770000016250030.2326
2022-06-30JPMorgan Small Cap Growth A1.14260.8749682332-5302-0.771
2022-03-31Eventide Healthcare & Life Sciences I0.99212.38159250019670049.6968
2022-06-30T. Rowe Price Small-Cap Stock0.98890.349659054912270026.2264
2022-06-30AB Small Cap Growth A0.85250.6464509129-5610-1.0899
2022-06-30Fidelity Advisor® Health Care I0.83720.46350000012405632.9985
Total 33.802913.694320187005  

3.3. Insider Transactions

Insiders are holding 0.689% of the shares of Blueprint Medicines Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-22Jeffrey W AlbersSELL841070.54183243
2022-08-19Jeffrey W AlbersSELL159070.02183243
2022-08-16Jeffrey W AlbersSELL2000068.41183243
2022-08-08Jeffrey W AlbersSELL1000070.07183243
2022-08-04Christopher K MurraySELL250060.4421320
2022-06-06Percy H CarterSELL190859.7628685
2022-04-06Jeffrey W AlbersSELL500070.11183243
2022-03-17George DemetriSELL1058.565812
2022-03-16L. Becker HewesSELL221960
2022-03-10Ariel HurleySELL233957.15
2022-03-07Ariel HurleySELL25656.19
2022-03-03Ariel HurleySELL76160.27
2022-03-03Mark Alan GoldbergBUY500059.98
2021-12-15L. Becker HewesSELL729100
2021-12-13Kate HavilandSELL100098.3
2021-12-07Tracey L MccainSELL500097.3
2021-11-15Jeffrey W AlbersSELL30000114.5
2021-11-15L. Becker HewesSELL729115.49
2021-11-03Tracey L MccainSELL5000110.56
2021-10-15L. Becker HewesSELL729102.66

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Blueprint Medicines Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--12.54316.282-23%24.086-48%14.788-15%10.160+23%
Current Ratio--5.9985.290+13%7.173-16%8.010-25%7.261-17%
Debt To Asset Ratio--0.3730.246+52%0.147+153%0.222+68%0.375-1%
Debt To Equity Ratio--0.5950.342+74%0.173+244%0.299+99%0.282+111%
Eps---2.679-2.967+11%1.515-277%-1.254-53%-1.010-62%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.971+3%
Net Profit Margin---4.370-3.471-21%-2.564-41%-22.333+411%-14.205+225%
Operating Margin---4.273-3.436-20%-2.572-40%-23.035+439%-14.594+242%
Operating Ratio--5.3134.449+19%3.573+49%42.410-87%27.643-81%
Pb Ratio5.228+23%4.0274.917-18%4.0400%5.932-32%4.653-13%
Pe Ratio-5.525-30%-4.256-8.568+101%17.542-124%-6.548+54%-6.298+48%
Peg Ratio--0.0140.032-55%-0.101+801%-0.450+3227%-0.388+2799%
Price Per Share65.570+23%50.51081.078-38%97.510-48%80.551-37%53.483-6%
Quick Ratio--9.8407.735+27%8.220+20%12.481-21%10.430-6%
Return On Assets---0.134-0.140+5%0.057-336%-0.083-38%-0.262+95%
Return On Equity---0.214-0.189-11%0.067-417%-0.114-46%-0.107-50%
 EOD+1 -2MRQTTM+7 -8YOY+4 -115Y+5 -1010Y+9 -7

4.2. Fundamental Score

Let's check the fundamental score of Blueprint Medicines Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.525
Price to Book Ratio (EOD)Between0-15.228
Net Profit Margin (MRQ)Greater than0-4.370
Operating Margin (MRQ)Greater than0-4.273
Quick Ratio (MRQ)Greater than19.840
Current Ratio (MRQ)Greater than15.998
Debt To Asset Ratio (MRQ)Less than10.373
Debt to Equity Ratio (MRQ)Less than10.595
Return On Equity (MRQ)Greater than0.15-0.214
Return on Assets (MRQ)Greater than0.05-0.134
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Blueprint Medicines Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.398
Ma 20Greater thanMa 5071.896
Ma 50Greater thanMa 10065.899
Ma 100Greater thanMa 20060.426
OpenGreater thanClose66.750
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Net non Operating Income Other  -373-149-522142-380-73-4531,085632



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,192,446
Total Liabilities444,696
Total Stockholder Equity747,750
 As reported
Total Liabilities 444,696
Total Stockholder Equity+ 747,750
Total Assets = 1,192,446

Assets

Total Assets1,192,446
Total Current Assets952,179
Long-term Assets952,179
Total Current Assets
Cash And Cash Equivalents 173,399
Short-term Investments 679,712
Net Receivables 29,410
Inventory 35,454
Other Current Assets 34,204
Total Current Assets  (as reported)952,179
Total Current Assets  (calculated)952,179
+/-0
Long-term Assets
Property Plant Equipment 119,020
Long Term Investments 94,048
Other Assets 27,199
Long-term Assets  (as reported)240,267
Long-term Assets  (calculated)240,267
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities158,760
Long-term Liabilities285,936
Total Stockholder Equity747,750
Total Current Liabilities
Short-term Debt 9,435
Accounts payable 15,053
Other Current Liabilities 119,282
Total Current Liabilities  (as reported)158,760
Total Current Liabilities  (calculated)143,770
+/- 14,990
Long-term Liabilities
Long term Debt Total 165,742
Other Liabilities 187,776
Long-term Liabilities  (as reported)285,936
Long-term Liabilities  (calculated)353,518
+/- 67,582
Total Stockholder Equity
Common Stock60
Retained Earnings -1,541,149
Accumulated Other Comprehensive Income -14,248
Capital Surplus 2,303,087
Total Stockholder Equity (as reported)747,750
Total Stockholder Equity (calculated)747,750
+/-0
Other
Capital Stock60
Cash and Short Term Investments 853,111
Common Stock Shares Outstanding 59,617
Common Stock Total Equity60
Current Deferred Revenue14,990
Liabilities and Stockholders Equity 1,192,446
Net Debt -65,804
Net Invested Capital 747,750
Net Tangible Assets 747,750
Net Working Capital 793,419
Short Long Term Debt Total 107,595



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
4,135
0
0
0
49,925
55,910
204,208
195,288
178,898
206,010
186,520
167,849
282,795
252,648
444,721
420,118
715,737
664,468
665,113
606,110
540,124
544,663
807,178
737,925
707,694
913,623
817,457
1,558,178
1,718,393
1,625,387
1,568,795
1,477,322
1,252,225
1,143,307
1,192,446
1,192,4461,143,3071,252,2251,477,3221,568,7951,625,3871,718,3931,558,178817,457913,623707,694737,925807,178544,663540,124606,110665,113664,468715,737420,118444,721252,648282,795167,849186,520206,010178,898195,288204,20855,91049,9250004,135
   > Total Current Assets 
0
0
0
0
48,274
52,180
201,443
188,587
170,416
197,667
178,120
159,448
220,425
213,958
431,328
400,279
685,505
615,698
622,213
565,657
499,787
426,516
612,952
513,726
516,786
704,683
568,312
841,655
927,759
937,710
704,070
771,848
554,025
687,244
952,179
952,179687,244554,025771,848704,070937,710927,759841,655568,312704,683516,786513,726612,952426,516499,787565,657622,213615,698685,505400,279431,328213,958220,425159,448178,120197,667170,416188,587201,44352,18048,2740000
       Cash And Cash Equivalents 
1,987
0
0
0
47,240
50,298
193,587
179,780
162,707
122,289
109,386
74,403
52,069
56,356
91,346
57,329
400,304
134,886
117,751
78,641
68,064
79,391
82,425
89,237
113,938
375,168
288,678
565,221
684,636
697,966
534,317
553,593
209,948
37,199
173,399
173,39937,199209,948553,593534,317697,966684,636565,221288,678375,168113,93889,23782,42579,39168,06478,641117,751134,886400,30457,32991,34656,35652,06974,403109,386122,289162,707179,780193,58750,29847,2400001,987
       Short-term Investments 
0
0
0
0
119
119
119
119
119
69,218
63,167
78,141
162,090
150,040
329,668
333,323
273,052
472,439
495,705
480,995
425,948
336,465
510,436
404,205
369,616
291,596
233,120
192,209
187,213
153,995
94,032
148,285
267,166
549,627
679,712
679,712549,627267,166148,28594,032153,995187,213192,209233,120291,596369,616404,205510,436336,465425,948480,995495,705472,439273,052333,323329,668150,040162,09078,14163,16769,2181191191191191190000
       Net Receivables 
0
0
0
0
3,414
484
1,923
2,470
3,414
4,232
3,351
3,455
3,577
2,826
3,075
3,435
0
0
0
0
215
0
5,264
5,076
23,412
25,107
24,280
61,256
25,309
43,863
39,240
29,724
37,030
32,598
29,410
29,41032,59837,03029,72439,24043,86325,30961,25624,28025,10723,4125,0765,264021500003,4353,0752,8263,5773,4553,3514,2323,4142,4701,9234843,4140000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,665
4,359
5,565
8,581
16,030
15,211
16,570
21,817
30,145
35,454
35,45430,14521,81716,57015,21116,0308,5815,5654,3592,6650000000000000000000000000
   > Long-term Assets 
0
0
0
0
1,651
3,730
2,765
6,701
8,482
8,343
8,400
8,401
62,370
38,690
13,393
19,839
30,232
48,770
42,900
40,453
40,337
118,147
194,226
224,199
190,908
208,940
249,145
716,523
790,634
687,677
864,725
705,474
698,200
456,063
240,267
240,267456,063698,200705,474864,725687,677790,634716,523249,145208,940190,908224,199194,226118,14740,33740,45342,90048,77030,23219,83913,39338,69062,3708,4018,4008,3438,4826,7012,7653,7301,6510000
       Property Plant Equipment 
1,404
0
0
0
1,482
1,295
1,393
4,805
6,661
6,537
6,565
6,578
6,188
6,081
7,774
13,416
24,363
29,074
30,250
29,720
29,627
30,615
33,525
38,310
38,361
37,822
36,745
104,219
101,668
98,978
96,294
94,190
120,862
119,229
119,020
119,020119,229120,86294,19096,29498,978101,668104,21936,74537,82238,36138,31033,52530,61529,62729,72030,25029,07424,36313,4167,7746,0816,1886,5786,5656,5376,6614,8051,3931,2951,4820001,404
       Long Term Investments 
0
0
0
0
54,059
0
0
0
0
0
0
0
54,059
29,929
0
0
0
13,798
3,195
0
0
0
74,398
101,017
64,406
83,666
128,475
598,470
677,873
578,168
751,702
591,920
557,529
306,525
94,048
94,048306,525557,529591,920751,702578,168677,873598,470128,47583,66664,406101,01774,3980003,19513,79800029,92954,059000000054,0590000
       Long-term Assets Other 
0
0
0
0
169
2,435
1,372
1,896
1,821
1,806
1,835
1,823
2,123
2,680
5,619
6,423
5,869
5,898
9,455
10,733
10,710
11,004
11,048
10,905
15,388
15,549
13,454
13,834
11,093
10,531
16,729
19,364
19,809
30,309
27,199
27,19930,30919,80919,36416,72910,53111,09313,83413,45415,54915,38810,90511,04811,00410,71010,7339,4555,8985,8696,4235,6192,6802,1231,8231,8351,8061,8211,8961,3722,4351690000
> Total Liabilities 
5,631
0
0
0
14,496
31,187
34,619
37,146
34,919
76,351
73,958
70,139
69,717
64,426
70,632
78,878
91,767
93,595
112,181
116,814
121,115
200,450
214,351
221,581
243,335
230,692
236,090
238,178
248,305
225,366
239,991
230,235
281,490
261,641
444,696
444,696261,641281,490230,235239,991225,366248,305238,178236,090230,692243,335221,581214,351200,450121,115116,814112,18193,59591,76778,87870,63264,42669,71770,13973,95876,35134,91937,14634,61931,18714,4960005,631
   > Total Current Liabilities 
3,153
0
0
0
6,764
14,630
14,451
19,291
18,640
23,782
27,754
24,380
28,512
25,759
32,992
35,490
42,890
39,998
50,333
56,279
60,323
64,763
81,506
94,142
106,482
98,288
105,086
110,108
130,802
112,437
125,397
119,691
149,765
137,025
158,760
158,760137,025149,765119,691125,397112,437130,802110,108105,08698,288106,48294,14281,50664,76360,32356,27950,33339,99842,89035,49032,99225,75928,51224,38027,75423,78218,64019,29114,45114,6306,7640003,153
       Short-term Debt 
0
0
0
0
1,704
2,127
2,552
2,978
3,266
3,272
3,033
2,792
2,551
2,140
1,979
1,818
1,518
1,106
692
277
0
0
0
0
0
0
0
7,672
7,935
8,193
8,465
8,810
8,093
8,762
9,435
9,4358,7628,0938,8108,4658,1937,9357,67200000002776921,1061,5181,8181,9792,1402,5512,7923,0333,2723,2662,9782,5522,1271,7040000
       Short Long Term Debt 
0
0
0
0
1,704
0
0
0
3,266
0
3,611
3,370
2,551
2,718
2,671
1,818
1,518
1,106
692
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006921,1061,5181,8182,6712,7182,5513,3703,61103,2660001,7040000
       Accounts payable 
1,414
0
0
0
814
6,738
5,649
9,371
8,891
8,108
10,337
9,258
13,957
12,628
19,977
25,889
34,285
32,375
42,788
49,169
55,009
55,247
70,734
82,622
93,499
82,429
89,653
92,045
4,370
2,889
1,847
9,549
8,333
17,961
15,053
15,05317,9618,3339,5491,8472,8894,37092,04589,65382,42993,49982,62270,73455,24755,00949,16942,78832,37534,28525,88919,97712,62813,9579,25810,3378,1088,8919,3715,6496,7388140001,414
       Other Current Liabilities 
1,031
0
0
0
4,246
5,765
6,250
6,942
6,483
12,402
14,384
12,330
12,004
10,991
11,036
7,783
7,087
6,517
6,853
6,833
5,314
9,516
10,772
11,520
12,983
15,859
15,433
89,116
118,497
101,355
107,173
101,332
121,829
100,698
119,282
119,282100,698121,829101,332107,173101,355118,49789,11615,43315,85912,98311,52010,7729,5165,3146,8336,8536,5177,0877,78311,03610,99112,00412,33014,38412,4026,4836,9426,2505,7654,2460001,031
   > Long-term Liabilities 
0
0
0
0
7,732
16,557
20,168
17,855
16,279
52,569
46,204
45,759
41,205
38,667
37,640
43,388
48,877
53,597
61,848
60,535
60,792
135,687
132,845
127,439
136,853
132,404
131,004
128,070
117,503
112,929
114,594
110,544
131,725
124,616
285,936
285,936124,616131,725110,544114,594112,929117,503128,070131,004132,404136,853127,439132,845135,68760,79260,53561,84853,59748,87743,38837,64038,66741,20545,75946,20452,56916,27917,85520,16816,5577,7320000
       Long term Debt Total 
0
0
0
0
0
6,525
5,710
4,893
4,072
3,246
2,672
2,095
1,518
1,106
692
277
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165,742
165,7420000000000000000002776921,1061,5182,0952,6723,2464,0724,8935,7106,52500000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,704
-2,127
-2,552
-2,978
-3,266
-3,272
-3,033
-2,792
-2,551
-2,140
-1,979
-1,818
-1,518
-1,106
-692
-277
0
99,600
99,003
97,508
95,949
94,836
93,143
83,735
81,669
79,477
77,272
75,054
103,315
100,762
98,160
98,160100,762103,31575,05477,27279,47781,66983,73593,14394,83695,94997,50899,00399,6000-277-692-1,106-1,518-1,818-1,979-2,140-2,551-2,792-3,033-3,272-3,266-2,978-2,552-2,127-1,7040000
       Warrants
0
0
0
0
0
403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000040300000
       Long-term Liabilities Other 
0
0
0
0
0
147
3,843
3,734
3,622
3,507
3,389
3,148
2,946
2,813
3,180
8,542
14,748
14,277
14,044
55,629
55,662
135,687
132,845
127,439
136,853
132,404
131,004
128,070
117,503
7,355
6,957
6,885
131,725
124,616
120,194
120,194124,616131,7256,8856,9577,355117,503128,070131,004132,404136,853127,439132,845135,68755,66255,62914,04414,27714,7488,5423,1802,8132,9463,1483,3893,5073,6223,7343,84314700000
       Deferred Long Term Liability 
0
0
0
0
99
9,482
10,514
8,523
8,585
45,816
40,143
40,516
36,741
34,748
33,768
34,569
34,129
4,389
4,648
4,906
5,130
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000005,1304,9064,6484,38934,12934,56933,76834,74836,74140,51640,14345,8168,5858,52310,5149,482990000
> Total Stockholder Equity
0
0
0
0
35,429
-90,085
169,589
158,142
143,979
129,659
112,562
97,710
213,078
188,222
374,089
341,240
623,970
570,873
552,932
489,296
419,009
344,213
592,827
516,344
464,359
682,931
581,367
1,320,000
1,470,088
1,400,021
1,328,804
1,247,087
970,735
881,666
747,750
747,750881,666970,7351,247,0871,328,8041,400,0211,470,0881,320,000581,367682,931464,359516,344592,827344,213419,009489,296552,932570,873623,970341,240374,089188,222213,07897,710112,562129,659143,979158,142169,589-90,08535,4290000
   Retained Earnings -1,541,149-1,381,440-1,275,441-956,755-839,514-731,070-631,356-545,688-1,179,666-1,056,194-945,238-878,908-784,633-684,952-597,545-517,223-444,501-417,452-355,589-306,562-268,859-235,447-207,470-186,206-169,373-150,479-134,975-119,400-106,758-93,778-82,2060000
   Accumulated Other Comprehensive Income 
0
0
0
0
-1,546
0
0
0
-2,077
-2,077
0
0
-3,268
-3,268
0
0
-4,644
-1,000
0
0
-8,655
-9,746
1,000
1,000
-3,000
-15,255
-1,000
-1,940
-5,214
-5,097
-5,835
-5,673
-4,133
-12,110
-14,248
-14,248-12,110-4,133-5,673-5,835-5,097-5,214-1,940-1,000-15,255-3,0001,0001,000-9,746-8,65500-1,000-4,64400-3,268-3,26800-2,077-2,077000-1,5460000
   Capital Surplus 
0
0
0
0
0
3,691
276,320
277,515
278,927
280,080
281,853
283,862
420,533
423,750
643,223
647,928
979,785
988,872
997,770
1,006,812
1,016,690
1,029,046
1,376,484
1,394,566
1,412,083
1,739,140
1,762,099
1,867,572
2,106,600
2,136,130
2,174,094
2,209,456
2,250,250
2,275,156
2,303,087
2,303,0872,275,1562,250,2502,209,4562,174,0942,136,1302,106,6001,867,5721,762,0991,739,1401,412,0831,394,5661,376,4841,029,0461,016,6901,006,812997,770988,872979,785647,928643,223423,750420,533283,862281,853280,080278,927277,515276,3203,69100000
   Treasury Stock00000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue180,080
Cost of Revenue-17,934
Gross Profit162,146162,146
 
Operating Income (+$)
Gross Profit162,146
Operating Expense-804,127
Operating Income-641,981-641,981
 
Operating Expense (+$)
Research Development601,033
Selling General Administrative195,293
Selling And Marketing Expenses-
Operating Expense804,127796,326
 
Net Interest Income (+$)
Interest Income-
Interest Expense--2,386
Net Interest Income2,3862,386
 
Pretax Income (+$)
Operating Income-641,981
Net Interest Income2,386
Other Non-Operating Income Expenses-1,489
Income Before Tax (EBT)-641,084-642,878
EBIT - interestExpense = -638,698
-641,084
-646,471
Interest Expense-2,386
Earnings Before Interest and Taxes (ebit)-641,084-643,470
Earnings Before Interest and Taxes (ebitda)-634,605
 
After tax Income (+$)
Income Before Tax-641,084
Tax Provision-3,001
Net Income From Continuing Ops-644,085-644,085
Net Income-644,085
Net Income Applicable To Common Shares-644,085
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses822,061
Total Other Income/Expenses Net897-897
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
9 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
9 hours ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
9 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
9 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
9 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart